While the health risks associated with adult cigarette smoking have been well described, effects of nicotine exposure during periods of developmental vulnerability are often overlooked. Using MEDLINE and PubMed literature searches, books, reports and expert opinion, a transdisciplinary group of scientists reviewed human and animal research on the health effects of exposure to nicotine during pregnancy and adolescence. A synthesis of this research supports that nicotine contributes critically to adverse effects of gestational tobacco exposure, including reduced pulmonary function, auditory processing defects, impaired infant cardiorespiratory function, and may contribute to cognitive and behavioral deficits in later life. Nicotine exposure during adolescence is associated with deficits in working memory, attention, and auditory processing, as well as increased impulsivity and anxiety. Finally, recent animal studies suggest that nicotine has a priming effect that increases addiction liability for other drugs. The evidence that nicotine adversely affects fetal and adolescent development is sufficient to warrant public health measures to protect pregnant women, children, and adolescents from nicotine exposure.
Background
After decades of declining cigarette sales, cigarette companies expanded their product lines to include a range of nicotinecontaining products with varying levels of toxicity, including smokeless tobacco in the 1990s, and electronic cigarettes and other types of electronic nicotine delivery systems (ENDS) in the early 2000s. Some tobacco companies have also added nicotine replacement therapy (NRT) pharmaceuticals (Aguinaga Bialous and Peeters, 2012; Newswire, 2016; Kostygina et al., 2016) . Electronic cigarettes-devices which create an aerosol for inhalation by heating a liquid solution that typically contains propylene glycol and/or glycerin, flavorings, and nicotine-have experienced rapid growth since their introduction into the US market (Grana et al., 2014; Singh et al., 2016; King et al., 2015) . However, their arrival has also engendered debate in the public health community (Etter, 2013; Chapman, 2013) . Those concerned about the risks from electronic cigarettes to individual and population level health note that electronic cigarettes could perpetuate conventional cigarette use in smokers who use both products instead of quitting cigarettes completely, and that adolescent users of these products could progress to conventional cigarette use (Grana et al., 2014; Primack et al., 2015; Leventhal et al., 2015) . In contrast, others contend that electronic cigarettes have lower toxicity than conventional cigarettes, higher consumer appeal than NRT, and that their use may lead to cessation or to a reduction in toxicant exposure, thereby reducing the burden of tobacco-related death and disease (Wagener et al., 2012) .
A key assertion advanced by those in favor of wide access to electronic cigarettes is that nicotine exposure presents a minimal health risk for most adult tobacco users (Fagerstrom and Bridgman, 2014) . This is based, in part, on longitudinal studies of adults exposed to nicotine from smokeless tobacco or NRT, which found lowered risk for myocardial infarction, stroke, and lung cancer compared with risk in cigarette smokers (Piano et al., 2010; Boffetta and Straif, 2009; U.S. Department of Health and Human Services, 2014; Boffetta et al., 2005) . However, this assertion has important limitations. Electronic cigarette use is not limited to adults or to conventional cigarette smokers (Collaco et al., 2015) . Use has increased dramatically in high school and middle school students since 2011, (Singh et al., 2016) and in 2014, twice as many youth used electronic cigarettes alone as in combination with cigarettes (Lee et al., 2015) . Furthermore, as will be presented here, conclusions about the risks of nicotine exposure based on studies in adults cannot be extrapolated to adolescents or pregnant women and their fetuses, because these populations have health risks unique to their particular stages of development. Nevertheless, discussions of the potential adverse health effects of nicotine among pregnant women and adolescents are often absent from discussions related to the public health impact of electronic cigarettes.
In May of 2015, scientists from varied disciplines were convened by the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to review the scientific literature on the health effects of nicotine exposure during periods of developmental vulnerability. In this expert review, meeting participants used MEDLINE and PubMed literature searches, books, reports, and expert opinion to summarize and synthesize relevant epidemiological, clinical, and preclinical research on the health effects of exposure to tobacco and nicotine pregnancy and adolescence. Electronic cigarettes were introduced to markets relatively recently, and their effects on health outcomes in pregnant women and adolescents have not been directly assessed. In addition, there are no published studies of developmental outcomes using animal models nicotine exposure from electronic cigarettes. Therefore, the authors draw on studies of other forms of tobacco exposure (cigarettes and smokeless tobacco) in humans and conventional nicotine exposure in animals. While there is evidence from animal models that gestational nicotine exposure also affects several organ systems, including renal, hematopoietic, adipose and endocrine (Ojeda et al., 2016; Shariati Kohbanani et al., 2016; Chen et al., 2015; Serobyan et al., 2005; Somm, 2014) , we focused on the central nervous and pulmonary systems, which are the most established and clearest targets of nicotine. In addition, shorterterm studies of exposures to electronic cigarette-derived aerosols in adult mouse models demonstrate that electronic cigarettes can produce pulmonary and behavioral effects similar to those seen with conventional nicotine exposures (Sussan et al., 2015; Lerner et al., 2015; Garcia-Arcos et al., 2016; Ponzoni et al., 2015) .
The implications of the increasing use of nicotine-containing products, specifically electronic cigarettes, for pregnant women and adolescents are discussed, and potential strategies for minimizing exposure in these populations are presented.
Tobacco use and nicotine exposure during pregnancy

Pregnancy outcomes
Maternal cigarette smoking during pregnancy is causally associated with a number of adverse pregnancy outcomes, including ectopic pregnancy, fetal growth restriction, preterm birth, placental abruption, and orofacial cleft defects (U.S. Department of Health and Human Services, 2014) . Despite high awareness that smoking increases the risk of pregnancy complications (Polen et al., 2015) , over 10% of U.S. women smoke cigarettes during pregnancy, exposing more than 400,000 fetuses each year (Tong et al., 2013) . Tobacco smoke contains thousands of chemicals, many of which could contribute to adverse outcomes (U.S. Department of Health and Human Services, 2010) . However, studies of pregnant women who are exposed to nicotine without products of combustion through the use of smokeless tobacco products can provide insight into the potential role of nicotine. These studies have found associations with preterm birth, stillbirth, and orofacial cleft defects (U.S. Department of Health and Human Services, 2014; Gupta and Subramoney, 2006; Baba et al., 2012; Wikstrom et al., 2010; England et al., 2013; Gunnerbeck et al., 2014) , but no clear association with fetal growth restriction (Baba et al., 2013; England et al., 2003; Juarez and Merlo, 2013; England et al., 2012) . In agreement with the latter finding, animal models utilizing nicotine alone do not demonstrate any consistent effect on fetal growth at exposures modeling those in typical smokers (Navarro et al., 1989; Birnbaum et al., 1994; Hussein et al., 2007) . Together, these findings provide evidence that nicotine and other tobacco smoke components produce distinctive adverse pregnancy outcomes.
Fetal brain development
During development, neurotransmitters control and coordinate the cellular and architectural assembly of the central nervous system (Lauder, 1985; Whitaker-Azmitia, 1991) . At the appropriate developmental phase, stimulation of neurotransmitter receptors regulates brain assembly by (1) promoting cell replication; (2) initiating differentiation; (3) initiating and then terminating axonogenesis and synaptogenesis; (4) regulating cell death; and (5) promoting cell migration to specific brain regions.
Acetylcholine plays a critical role in brain maturation via activation of nicotinic acetylcholine receptors (nAChRs). These receptors are a structurally diverse family of ligand-gated ion channels which regulate synaptic plasticity and brain development. Nicotine crosses the placenta (Luck et al., 1985) and specifically binds to nAChRs in the fetal brain (Cairns and Wonnacott, 1988; Hagino and Lee, 1985) . Since nAChRs are functional at early stages of brain development, their early activation and/or desensitization by nicotine can lead to long-term developmental disruption (Dwyer et al., 2008; Atluri et al., 2001; Schneider et al., 2002) . Even first-trimester exposure can induce disruption of brain development at both cellular and structural levels . Although the structural features may appear grossly normal by early adulthood (Roy et al., 2002) , a detailed analysis of synaptic architecture shows longlasting alterations (layer thinning, loss of neuropil, glial "scarring"), particularly in the hippocampus and somatosensory cortex-areas that are critical for attention and cognitive function (Roy et al., 2002; Roy and Sabherwal, 1998; Roy and Sabherwal, 1994) . Thus, from a morphological standpoint, nicotine is a subtle neuroteratogen. However, its functional consequences exceed the visible evidence of disrupted development.
In developing rats exposed prenatally to nicotine at plasma levels comparable to those in human active smokers, standard biomarkers of cell injury indicate apoptosis, reductions in the numbers of neuronal cells, truncation of axonogenesis, and deficient synaptogenesis (Slotkin, 2008; Pauly and Slotkin, 2008; Slotkin, 1999; Slotkin, 2002) . Neuronal damage and cell loss involving the activation of genes associated with apoptosis intensify in the postnatal period despite the discontinuation of nicotine exposure (Slotkin, 1999; Slotkin, 1998; Slotkin et al., 1997) . The developmental context is critical for evoking damage, since nicotine-induced apoptosis in the immature brain is distinct from its effect in the mature brain (Ferrea and Winterer, 2009; Kawamata and Shimohama, 2011) . For example, hippocampal progenitor cells show nicotine-induced apoptosis only during early differentiation (Berger et al., 1998) . Furthermore, the delayed-onset changes that occur when nicotine is no longer present in the system indicate that nicotine changes the entire trajectory of brain development so that adverse effects can emerge later in life, after a period of apparent normality. This is particularly important for patterns of synaptic activity that display initial deficits in the early postnatal period, but tend to recover by juvenile stages, only to show a reemergence of hypoactivity in adolescence (Slotkin, 1998; Slotkin, 2004; Levin and TAS, 1998; Slotkin, 1992) , at which point there is a persistent deficit in nAChR function (Liang et al., 2006; Britton et al., 2007; Abreu-Villaca et al., 2004; Seidler et al., 1992) .
To characterize the involvement of nAChRs in regulating brain development during the third trimester human fetal period, studies examined the effects of nicotine exposure during the functionallyequivalent early postnatal period in rats and found altered thalamocortical maturation, resulting in subsequent impairment of cognitive behaviors (Liang et al., 2006; Aramakis et al., 2000; Heath et al., 2010) . The hippocampus and cerebellum, which are both late maturing structures, also exhibited unique regulation by nAChRs (Liu et al., 2006; Leslie et al., 2002; Opanashuk et al., 2001 ; O'Leary and Leslie, 2003) , and consequently, postnatal nicotine exposure disrupted morphological assembly of these regions (Huang et al., 2007; Chen et al., 1998) . Thus, animal studies indicate that nicotine exposure can negatively impact all stages of fetal brain development. Indeed, it is estimated that nicotine is responsible for as much as 36%-46% of the overall impact of tobacco smoke on the development of brain circuitry in animal models (Slotkin et al., 2015) .
It is important to note that the adverse effects of nicotine on brain development occur at exposure levels that do not compromise somatic growth (Slotkin, 2004) . Maternal cigarette smoking is strongly associated with intrauterine growth retardation, a wellrecognized predictor of poor perinatal outcomes (U.S. Department of Health and Human Services, 2014). However, because nicotine targets the fetal brain, damage can be present, even when birth weight is normal. This reflects the specific actions of nicotine on nAChRs that modulate neuronal development, in contrast to nonspecific fetal insults, which typically spare brain development at the expense of fetal somatic growth (Slotkin, 2004; Bell et al., 1987; de Grauw et al., 1986) .
The effects of isolated nicotine exposure on human fetal brain development have not been studied directly. However, maternal cigarette smoking has measurable effects on brain structure that are consistent with animal models that evaluated nicotine alone. Imaging studies found that fetuses exposed to maternal smoking had decreased transcerebellar and lateral ventricle diameter/width (ultrasound) and decreased overall brain volume (MRI) compared with unexposed fetuses, as well as smaller frontal lobe and cerebellar volumes in infancy (Anblagan et al., 2013; Ekblad et al., 2010; Roza et al., 2007) . Imaging studies of offspring in later life also found differences in the brains of exposed offspring, including reduced cerebral cortical gray matter, reduced subcortical gray matter volumes in the amygdala, thalamus, and pallidum, and reduced volume in the corpus callosum (Rivkin et al., 2008; Paus et al., 2008; Toro et al., 2008; Lotfipour et al., 2009; Haghighi et al., 2013; Liu et al., 2013a) . In a study of 6-to 8-year-old children prenatally exposed to maternal smoking, the authors found reduced brain volume, smaller cortical gray and white matter volumes, and thinning of the superior frontal, superior parietal, lateral occipital, and precentral cortices compared with age-and gender-matched unexposed children (El Marroun et al., 2014) . Taken together, studies of tobacco exposure in human fetuses are in agreement with those of nicotine exposure in animals, and in particular, those which documented disruption of brain development independent of effects on fetal growth (Ekblad et al., 2010; Haghighi et al., 2013; El Marroun et al., 2014) . The structural alterations seen in human studies are paralleled by functional changes in the fetus. Studies using realtime fetal monitoring (Nijhuis et al., 1982; Groome et al., 1995; DiPietro et al., 2010; Dipietro, 2010) found greater rates of maladaptive response to the non-stress test (a clinical index of fetal well-being) (Oncken et al., 2002) , including reduced heart rate variability, increased mouth and self-touch movements, and impaired recognition of maternal voice in fetuses of smokers compared with those of nonsmokers (Cowperthwaite et al., 2007; Zeskind and Gingras, 2006; Reissland et al., 2015) .
Perinatal mortality and sudden infant death syndrome
Maternal smoking during pregnancy increases the risk of perinatal mortality (which includes both stillbirth and neonatal death) by 20-30% (DiFranza and Lew, 1995) , and of sudden infant death syndrome (SIDS) 2.4-3-fold . Maternal smokeless tobacco use in pregnancy is associated with a 1.6-2.6-fold increase in stillbirth (Gupta and Subramoney, 2006; Wikstrom et al., 2010) .
Maternal smoking is thought to increase perinatal mortality and SIDS risk in part through its effects on fetal and infant stress responses. Human parturition is associated with an extended period of hypoxia, and the fetus and newborn possess unique adaptive responses that maintain cardiovascular function during this period. These responses center around circulatory adjustments that ensure adequate perfusion of the brain and heart, and require autonomous secretion of catecholamines from the adrenal medulla (Lagercrantz and Slotkin, 1986) , as well as a myocardium that is adapted to function in a low oxygen environment (Ascuitto and Ross-Ascuitto, 1996; Briggs et al., 1992) . Prenatal nicotine exposure leads to severe reduction or loss of the adrenomedullary component, along with a reduced cardiac response to adrenergic stimulation, resulting in brain injury or death during a hypoxic episode that would ordinarily not be harmful (Slotkin, 1998; Slotkin et al., 1997; Slotkin et al., 1995) . Although animal studies provide the primary evidence for this mechanism, the same deficiency in adrenomedullary function in response to hypoxia has been identified in the offspring of smokers at birth (Oncken et al., 2003) . The loss of cardiovascular adaptation caused by maternal smoking affects the fetus during delivery, when hypoxic events can evoke stillbirth or birth asphyxia, as well as during infancy, when hypoxic events can result in SIDS .
Additional contributions of maternal smoking to SIDS risk likely entail effects on central cardiorespiratory control and arousal. Maturation of sleep architecture and sleep during the first year of life includes changes in both respiratory and cardiovascular control (Horne et al., 2005) . Infants, especially those born preterm, are at increased risk for cardiorespiratory disturbances, apnea, and hypoxemia during sleep, events for which arousal is an important protective response. Failure of this response mechanism could contribute to SIDS risk (Richardson et al., 2009; McNamara and Sullivan, 2000; Schneider et al., 2008) . Maternal smoking and smokeless tobacco use during pregnancy are associated with increased risk of neonatal apnea, while maternal smoking is also associated with a decreased arousal response (Richardson et al., 2009; Kahn et al., 1994; Franco et al., 1999; Horne et al., 2004; Sawnani et al., 2004; Stephan-Blanchard et al., 2010; Gunnerbeck et al., 2011; Chang et al., 2003) . The administration of nicotine to pregnant ewes can evoke the same deficit in newborn lambs (Hafstrom et al., 2002) . In addition, there is evidence that prenatal nicotine exposure damages brainstem circuits that are responsible for mounting appropriate respiratory responses to neonatal hypoxia, which could contribute to additional SIDS risk (Campos et al., 2009; Kinney, 2009 ).
Infant stress response
Maternal smoking during pregnancy in humans leads to alterations in behavior and stress responsiveness in newborns, in addition to the specific effects on hypoxic stress discussed above. Specifically, studies of the immediate neonatal period (postnatal days 1-5) revealed increased signs of abstinence/withdrawal, hypertonicity, irritability, and excitability in tobacco-exposed neonates, with a clear dose-response relationship to nicotine exposure (Stroud et al., 2009a; Law et al., 2003; Hurt et al., 2005; Mansi et al., 2007; Godding et al., 2004) . Studies later in the neonatal period (10-30 days) found continued or emerging behavioral effects on self-regulation, attention, need for external soothing or handling, and arousal-all potentially portending longer-term effects on attention and regulation (Stroud et al., 2009b; Yolton et al., 2009; Espy et al., 2011) . Several studies also found alterations in stress responses in exposed infants. For example, the stress hormone, cortisol, was increased in the cord blood of newborns of smoking mothers Varvarigou et al., 2006; Varvarigou et al., 2009) , and infants aged 1-7 months showed altered cortisol response to stress (Ramsay et al., 1996; Schuetze et al., 2008; Stroud et al., 2014) . There is extensive scientific literature on the long-term neurobehavioral deficits associated with early life exposure to prolonged stress and/or excessive glucocorticoid hormones (reviewed by Maccari et al. (Maccari et al., 2003) ). Similarly, animal studies found evidence that prenatal nicotine exposure disrupts stress hormone regulation in offspring (Poland et al., 1994a; Poland et al., 1994b; Poland et al., 1996) . For example, in one study, adult male rats with gestational exposure to nicotine showed abnormal neuroendocrine responses to stress (Poland et al., 1994a) .
Auditory processing
A number of studies have examined maternal smoking and infant auditory processing (Kable et al., 2009; Katbamna et al., 2013; Korres et al., 2007; Peck et al., 2010) . Healthy newborn infants of non-smoking mothers discriminated among a greater number of syllables whereas healthy newborns of smokers began the discrimination process at least 150 ms later and differentiated fewer stimuli (Key et al., 2007) . Effects on auditory processing may persist beyond infancy; an increased risk of low-frequency hearing loss has been documented in adolescent offspring of women who smoked during pregnancy (Weitzman et al., 2013) . Animal research supports that nicotine adversely affects auditory processing (Aramakis et al., 2000; Lacy et al., 2011) . Exposure of rats to nicotine in the second postnatal week, corresponding to the third trimester of human fetal brain development (Rodier, 1988) , disrupted the development of glutamate synapses in the auditory cortex, which has been associated with long-term deficits in auditory processing and learning (Liang et al., 2006; Aramakis et al., 2000) .
Outcomes in childhood and adolescence
Numerous studies have addressed the long-term consequences of maternal smoking during pregnancy on offspring behavior. The most consistent associations are with externalizing and disruptive behaviors, such as conduct disorder (antisocial personality disorder in adults) and oppositional defiant disorder, from infancy through adulthood, as well as the precursors of these behaviors (Ernst et al., 2001; Wakschlag et al., 2002 ). However, a major limitation of traditional approaches to studies of prenatal tobacco exposure and behavioral outcomes has been the inability to fully control for potential confounding factors, particularly family environment and genetic factors (D'Onofrio et al., 2008) . More recently, high quality, prospective studies using multimethod exposure measurement and propensity score modeling have delineated a coherent pattern of disruptive behavior associated with prenatal tobacco exposure, beginning in early childhood (Gaysina et al., 2013; Wiebe et al., 2015) . For example, adoption studies provide support for an independent effect of maternal smoking during pregnancy on externalizing behaviors (Gaysina et al., 2013) . A recent sibling study that included detailed exposure data and careful control for family-level effects found modest, but statistically significant associations between tobacco exposure and conduct disorder symptoms and oppositional defiant disorder symptoms (Estabrook et al., 2015) . Both associations were similar in magnitude to contributions from genetics and family environment described in prior work. These studies add evidence supporting a role for prenatal tobacco exposure in increased risk for externalizing behaviors.
Associations have also been described between maternal smoking during pregnancy and offspring internalizing behaviors (anxiety and depression), attention deficit hyperactivity disorder (ADHD), and impairments in learning and memory, but are less consistent than for externalizing behaviors (D'Onofrio et al., 2008; Ashford et al., 2008; Brion et al., 2010; Williams et al., 1998; Roza et al., 2009; Robinson et al., 2010; Moylan et al., 2015; Carter et al., 2008; Yolton et al., 2014; Thapar et al., 2009; Milberger et al., 1998; Fried et al., 1992a; Fried et al., 1992b; Cornelius et al., 2001; Makin et al., 1991; Lambe et al., 2006; Sexton et al., 1990; Batstra et al., 2003; Eskenazi and Trupin, 1995; Clifford et al., 2012; Yang et al., 2013; Knopik, 2009; Mortensen et al., 2005; Treur et al., 2015) . These inconsistencies illustrate the difficulty in determining cause-and-effect relationships for different outcomes in diverse human populations with multiple confounders and risk factors for neurobehavioral deficits, especially when the associated behavior may not emerge for years after the injurious exposure.
Animal models have been used to assess the role of prenatal nicotine exposure on developmental and long-term behavioral outcomes. Reflex behaviors characterize the development of sensory and motor systems in the brain, and rodent studies suggest that prenatal nicotine exposure delays maturation of reflexes, including negative geotaxis and surface righting (measures of limb coordination and locomotor development), as well as causing long-lasting alterations in filtering auditory information. (Lacy et al., 2011; Sobrian et al., 1995; Gaworski et al., 2004; Schneider et al., 2011) However, these findings are not entirely consistent; some studies found normal reflex development in exposed animals (reviewed by Sobrian and Holson (Sobrian and Holson, 2011) ). Activity levels have also been studied using rodent models, again with inconsistent results, perhaps reflecting differences in the developmental exposure period and the method of nicotine administration, or, in some cases, lack of sufficient statistical power in the experimental design (Sobrian and Holson, 2011) .
In contrast, there is greater consistency among animal studies examining the effects of prenatal nicotine exposure on cognitive development, suggestive of global impairments in learning and memory (Vaglenova et al., 2004; Portugal et al., 2012; Cutler et al., 1996; Levin et al., 1993; Levin et al., 1996; Sorenson et al., 1991; Nakauchi et al., 2015; Ankarberg et al., 2001; Eppolito and Smith, 2006; Yanai et al., 1992) . These effects appear to be dose dependent and sensitive to factors such as sex and timing of exposure. Research suggests that these deficits reflect effects on nAChR modulation of long-term potentiation in the hippocampus (Nakauchi et al., 2015) . Adverse outcomes on affective behavior have also been identified, including learned helplessness, fear trace conditioning, and anhedonia (Paz et al., 2007; Franke et al., 2008) . Combined gestational/neonatal exposure is associated with increased anxiety levels, poor adaptation in a new environment, and decreased novelty-seeking (Vaglenova et al., 2004; Eppolito et al., 2010; Sobrian et al., 2003) .
Pulmonary outcomes
Maternal smoking during pregnancy has adverse effects outside the central nervous system, most notably on lung development, causing lifelong decreases in pulmonary function (Hayatbakhsh et al., 2009; Moshammer et al., 2006; Cunningham et al., 1994; Hoo et al., 1998; Stocks et al., 2013) . At birth, and prior to any significant postnatal exposure to tobacco smoke, infants born to smokers show decreased pulmonary function tests, with decreased respiratory flows and respiratory compliance, and altered tidal breathing patterns. (Hoo et al., 1998; Stocks et al., 2013; McEvoy et al., 2014) These changes lead to increased risk in childhood of wheezing, hospitalization for respiratory infections, and asthma (Stoddard and Gray, 1997; Neuman et al., 2012; Burke et al., 2012) . Studies of the effects of nicotine on lung development have been performed in mice, rats, sheep and monkeys with strikingly similar results between animals and humans (Spindel and McEvoy, 2016) . In humans, the clearest, most consistently measured effect of maternal smoking during pregnancy on offspring respiratory health is decreased forced expiratory flow (Hayatbakhsh et al., 2009; Moshammer et al., 2006; Cunningham et al., 1994; Hoo et al., 1998) . In both monkeys and mice, exposure to prenatal nicotine alone, at levels similar to that of smokers, causes similar decreases in forced expiratory flow (Wongtrakool et al., 2012; Proskocil et al., 2005; Sekhon et al., 2001) . A primary mediator of this effect appears to be the ␣7 nAChR, as the effect of nicotine was lost in ␣7 nAChR knockout mice (Wongtrakool et al., 2012) .
Studies on non-human primates point to the potential mechanisms of nicotine's actions on lung development. Treatment of pregnant rhesus monkeys with nicotine causes marked increases of levels of ␣7 nAChR in fibroblasts surrounding airways and blood vessels in the fetal monkey lung, and increases in collagen in a similar distribution (Sekhon et al., 1999; Sekhon et al., 2002; Sekhon et al., 2004) . Similar effects are seen in mice (Wongtrakool et al., 2012) . The increased collagen and decreased elastin caused by prenatal nicotine exposure likely underlies the decreases in lung compliance seen in the offspring of smokers. Prenatal nicotine exposure leads to thickening of walls surrounding airways and pulmonary vessels in animal models (Sekhon et al., 2002; Sekhon et al., 2004) , a finding that has also been reported in the human offspring of smokers (Elliot et al., 1998; Lavezzi et al., 2014) , along with similar increases in connective tissue and ␣7 expression (Lavezzi et al., 2014) . In addition, consistent with the long term effects on offspring pulmonary function and increased risk of asthma associated with maternal smoking during pregnancy in humans, smoking during pregnancy causes long-lasting changes in DNA methylation if offspring (Joubert et al., 2016) that are observed in fetal lung (Chhabra et al., 2014) , cord blood (Chhabra et al., 2014) , and which continue to be present in the blood of school-age children (Breton et al., 2014) . In rodent models, prenatal nicotine exposure causes similar DNA methylation changes, including changes in Runx1 methylation, which has been associated with increased risk of asthma (Liu et al., 2013b; Rehan et al., 2013; Rehan et al., 2012; Haley et al., 2011) , Research by Rehan and colleagues supports that DNA methylation changes caused by in utero nicotine exposure may persist for multiple generations (Rehan et al., 2013; Rehan et al., 2012) . Rodent models also suggest that prenatal tobacco exposure can cause decreased histone deacetylate activity in offspring lung, accompanied by changes in expression of the glucocorticoid receptor splice variant 1.7 (Suter et al., 2015) . While the immediate human clinical impact of these findings are unclear, they suggest that epigenomic modifications in important inflammatory and pulmonary maturation pathways (i.e., glucocorticoid receptors), may result from in utero nicotine exposure. Whether this ultimately translates into increased risk of asthma and pulmonary atopic disease among offspring remains unknown.
Tobacco use and nicotine exposure during adolescence
Tobacco use during adolescence
Tobacco use among adolescents in the United States is changing rapidly. While the prevalence of cigarette smoking has steadily declined over the past decade (Lee et al., 2015; Kann et al., 2014 ; Substance Abuse and Mental Health Services Administration, 2014; U.S. Department of Health and Human Services, 2012) , the use of alternative tobacco products, including electronic cigarettes, has increased (Mermelstein, 2014) . Conventional cigarettes were the most commonly used tobacco products by U.S. youth in 2013 (Arrazola et al., 2014) , and many youth who used electronic cigarettes-more than a quarter million-had never smoked combustible cigarettes (Bunnell et al., 2015) . A subsequent survey in 2014 and 2015 found that past-month e-cigarette use has surpassed conventional cigarette use among middle and high school students O'Malley et al., 2016) . Several longitudinal studies have found that electronic cigarette use at baseline is associated with increased risk of future use of combustible tobacco products (Primack et al., 2015; Leventhal et al., 2015; Wills et al., 2016; Barrington-Trimis et al., 2016) .
Brain development in adolescence
Concerns about nicotine toxicity do not end after birth or infancy. Brain development continues well into the third decade of life, and the adolescent and young adult brains differ from those of the fully mature adult, both physiologically and neurochemically. For example, adolescent synapses are more numerous and more "plastic," or moldable by experience (Schramm et al., 2002; Sowell et al., 2003; Giedd et al., 1999) . Hence, adolescents have superior learning and memory skills compared to adults, with synaptic formation and learning highly strengthened by stimulation from environmental experience (Burgaleta et al., 2014) . This feature of adolescent brain development can have detrimental consequences when inappropriate stimulation is evoked by exposure to neuroactive chemicals. For example, addictive stimuli or drugs can activate and strengthen reward circuits to create an addicted state (Russo et al., 2010) . Adolescents and young adults are thus more vulnerable to addiction than adults (U.S. Department of Health and Human Services, 2012) . In support of this, epidemiologic studies document that individuals who begin smoking as teens are more likely to become life-long smokers than those who start smoking in their 20's or later (Dierker et al., 2012; Hu et al., 2012; Volkow, 2006) . Furthermore, adolescents experience symptoms of dependence at lower levels of nicotine exposure than adults (O'Loughlin et al., 2003; DiFranza et al., 2000; Kandel and Chen, 2000) . Consequently, it is harder to reverse addiction originating in this stage compared with later in life (Brenhouse et al., 2008) . Animal studies confirm the heightened response of adolescents to nicotine exposure (Belluzzi et al., 2004) . Adolescent rodents self-administer nicotine more than adults and adolescent exposure leads to increased selfadministration of nicotine (Adriani et al., 2003) and other drugs in adulthood (Klein, 2001) .
The special vulnerability of the adolescent brain extends to areas involved in higher cognitive function, such as the prefrontal cortex where circuit formation continues into the 20s. During this extended maturational period, substantial neural remodeling occurs in a variety of pathways, including those governed by dopamine or acetylcholine. Dopamine is critical to reward function, and acetylcholine plays a central role in cognitive maturation, including executive function mediated by the prefrontal cortex (Wallace and Bertrand, 2013) .
Functional magnetic resonance imaging (fMRI) has been used in numerous studies of adult smokers to examine the neural circuitry involved in nicotine craving and addiction (McClernon et al., 2005; Due et al., 2002; Smolka et al., 2006; McBride et al., 2006; Sharma and Brody, 2009; Brody et al., 2006; Franklin et al., 2007; McClernon et al., 2008; Dagher et al., 2001 ), but in fewer studies of adolescent smokers (Rubinstein et al., 2011a; Rubinstein et al., 2011b; Jacobsen et al., 2007a; Jacobsen et al., 2007b; Lee et al., 2005; Galvan et al., 2011) . Peters et al. examined neural responses to anticipation of financial reward in adolescent smokers (age 14 years) (Peters et al., 2011) and found that they had smaller neural responses in the ventral striatum and midbrain compared to matched non-smoking controls. Moreover, the reduced response showed a clear-cut relationship with the frequency of smoking. These findings suggest that adolescent smokers display a hypo-responsivity to the anticipation of non-drug reward (i.e., financial reward) relative to non-smokers, and this hyporesponsivity becomes more severe with increased smoking. There is also evidence that adolescents who smoke ≤5 cigarettes per day display attenuated responses to other non-drug rewards, including pleasurable food images, relative to non-smokers, in areas including the insula and inferior frontal region (Rubinstein et al., 2011a) . The implication of both these studies is that the use of extremely rewarding drugs, such as nicotine, may decrease the perception of the pleasure obtained from non-drug rewards. Furthermore, the fact that this was demonstrated in young-and light-smoking teens indicates that such changes in the brain occur in early phases of smoking.
Cognitive outcomes
Nicotine withdrawal produces transient cognitive impairment and negative affective states, while smoking relapse alleviates these symptoms (reviewed by Hall et al. (Hall et al., 2015) ). In addition, adult smokers show more rapid cognitive decline with age than nonsmokers (Starr et al., 2007; Paelecke-Habermann et al., 2013; Williams et al., 2010; Heffernan et al., 2010; Heffernan et al., 2012) , although it is unclear whether the underlying mechanisms involve nicotine, products of combustion, or both (U.S. Department of Health and Human Services, 2014) . The few studies that have been done in adolescents and young adults also suggest that cigarette smoking has adverse effects on cognition (Jacobsen et al., 2005; Jacobsen et al., 2007c; Fried et al., 2006) . For example, one study found that current smokers aged 17-21 who smoked throughout their adolescence performed significantly worse than their nonsmoking counterparts on a variety of neurocognitive tasks, even after adjustment for educational attainment and family income (Fried et al., 2006) . In a separate study of adolescent daily smokers and nonsmokers who were similar in age, sex, and education, smokers showed impairments in accuracy of working memory performance, irrespective of recency of smoking (Jacobsen et al., 2005) . Earlier age at onset of smoking was associated with more severe performance decrements, and smokers experienced depressed mood and further disruption of working memory and verbal memory during abstinence. Furthermore, male smokers initiated smoking at an earlier age than females and were more impaired during tests of selective and divided attention than female smokers and nonsmokers. Abstinent adolescent smokers have also been found to exhibit reductions in the efficiency of their working memory neurocircuitry (Jacobsen et al., 2007c) . In a study of adolescent smokers and non-smokers who were similar with respect to age, education, IQ, parental education, and symptoms of inattention, prenatal and adolescent exposure to tobacco smoke were both associated with increased fractional anisotropy in anterior cortical white matter (Jacobsen et al., 2007a) . Disruption of auditory corticofugal fibers may interfere with the ability of these fibers to modulate ascending auditory signals, leading to greater noise and reduced efficiency of neurocircuitry that supports auditory processing. In a study of young adult non-abstinent smokers and non-smokers age 18-29 years who were matched for age, education, income, and sex, smokers showed significant cognitive impairments in sustained attention, spatial working memory, and executive planning (Chamberlain et al., 2012) . In a study of young adults age 18-35 years, the authors found prefrontal attentional network activity was reduced in smokers compared with non-smokers using fMRI, and the degree of diminished attentional network activity was correlated with the number of years participants had smoked (Musso et al., 2007) . Finally, cognitive deficits have also been associated with childhood and adolescent exposure to secondhand cigarette smoke (Chen et al., 2013; Yolton et al., 2005) .
The association between adolescent cigarette smoking and longlasting deficits in cognition is especially troubling because several mental health disorders that include changes in cognition are also associated with higher rates of tobacco use (Glassman et al., 1990; Jackson et al., 2015; Bakhshaie et al., 2015; de Leon et al., 1995; Lasser et al., 2000; McClernon et al., 2009; Vanable et al., 2003; Vogel et al., 2003) . For example, an elevated prevalence of cigarette smoking has been noted among individuals with schizophrenia, ADHD, depression, anxiety disorders, bipolar disorder, and others (Glasheen et al., 2014; Ziedonis et al., 2008) . There is evidence to support a bidirectional relationship-attributes that predispose individuals to these conditions could also predispose them to tobacco use and nicotine use-and addiction could result in or exacerbate symptoms accompanying these disorders (Hall et al., 2015; Kutlu et al., 2015) . Similar phenomena could occur in individuals with subclinical affective or cognitive disorders (Hall et al., 2015) .
Existing human studies of cognitive outcomes are mainly crosssectional in nature, making it difficult to determine whether tobacco use results from premorbid cognitive problems or causes these problems. However, studies of laboratory rodents provide strong evidence that isolated nicotine exposure during adolescence produces long-lasting deficits in learning and cognitive processes (Portugal et al., 2012; Goriounova and Mansvelder, 2012a; Spaeth et al., 2010; Goriounova and Mansvelder, 2012b; Poorthuis et al., 2009) . For example, adolescent nicotine exposure was associated with adult deficits in contextual fear conditioning, but not cued fear conditioning, in both rats and mice (Spaeth et al., 2010) , suggesting altered function in brain regions involved in contextual processing, such as the hippocampus. In support of altered hippocampal function, adolescent nicotine exposure was associated with reduced hippocampal CA1 dendritic length and apical dendritic branch complexity (Holliday et al., 2016) . The effects on learning were not seen in adults similarly exposed to nicotine (Portugal et al., 2012) . In addition, adult rats exposed to nicotine during adolescence had deficits in attention and displayed increased impulsivity (Counotte et al., 2011) . These cognitive deficits may be related to long-lasting changes in cellular processes involved in synaptic plasticity, as adolescent nicotine exposure altered adult medial prefrontal cortical long-term potentiation of synaptic activity (Goriounova and Mansvelder, 2012b) .
Animal studies also provide evidence for long-lasting changes in mental health-related behaviors after adolescent nicotine exposure (Slawecki et al., 2003; Iniguez et al., 2009; Ribeiro-Carvalho et al., 2011) . For example, adolescent nicotine exposure increased anxiety in adult rats , decreased the sensitivity to natural rewards, and fostered depression-like behaviors (Ribeiro-Carvalho et al., 2011) . Further, changes in anxiety related to adolescent nicotine exposure were associated with increased corticotropin-releasing factor, a neuropeptide involved in stress response initiation, in the hypothalamus and frontal cortex and frontal cortex and increased neuropeptide Y, a neuropeptide that may play a protective role in responses to stress, in the hypothalamus and hippocampus (Slawecki et al., 2005) . Together, these findings raise serious concerns about the long-term impact of adolescent nicotine exposure on mental health through adverse effects on cognition, anxiety, impulsivity, depression, and drug reward and reinforcement.
Trajectory of tobacco and other substances use
There is evidence that nicotine exposure in adolescence affects the use of other substances. In the U.S. population, the use of tobacco often precedes the use of other drugs including marijuana, which in turn generally precedes the use of cocaine and other illicit substances for those who go on to use other drugs (Viveros et al., 2006; Kandel, 2002; Kandel and Fung, 2002) . Although this pattern may reflect that tobacco is legal and easier to access than illicit substances, evidence from translational research in rodents supports a causal mechanism for the observed sequence of progression from tobacco to other drugs. Nicotine pretreatment in mice and rats enhances the subsequent response to cocaine, but the effect is unidirectional, as the reverse order (cocaine followed by nicotine) does not result in enhancement of the response to nicotine (Kandel and Kandel, 2014a; Dao et al., 2011; Mojica et al., 2014) . At the molecular level, nicotine exerts a priming effect by enhancing the ability of cocaine to induce FosB, a key mediator of addiction (Kandel and Kandel, 2014b; Levine et al., 2011) . It does so by inhibiting histone deacetylation. The consequent enhancement of gene expression leads to an increase in the response to cocaine in reward-based areas. These results provide a biological basis and a molecular mechanism for nicotine as a gateway drug.
Synthesis and conclusions
Historically, many clinicians and scientists have considered exposure to nicotine alone to be low risk, especially for established smokers. However, for pregnant women and adolescents, a large body of scientific evidence challenges this concept. As detailed in this review, existing human and animal research provides sufficient evidence for researchers and public health officials to draw a number of conclusions regarding the adverse effects of nicotine on human development. These conclusions could serve as a foundation for public health policy, planning, and practice regarding electronic cigarettes and other non-combustible tobacco products.
Animal models of prenatal nicotine exposure have successfully recapitulated the neurodevelopmental and behavioral phenotypes associated with maternal cigarette smoking during pregnancy (Slotkin, 2008; Pauly and Slotkin, 2008; Slotkin, 1999; Slotkin, 2004; Slotkin et al., 1993) , and these studies show that nicotine itself is a critical contributor to the harmful neurodevelopmental effects of tobacco smoke exposure (Slotkin et al., 2011; Golub et al., 2007; Slotkin et al., 2006; Slotkin et al., 2005) . Similarly, the combined results from animal and human studies of prenatal cigarette and nicotine exposure provide consistent evidence that fetal nicotine exposure adversely affects lung development in utero, in infancy, and in childhood (Spindel and McEvoy, 2016) . It is likely that the use of nicotine-containing products by pregnant women, including electronic cigarettes, will have effects on pulmonary development that are similar to those observed in the offspring of cigarette smokers. While there is evidence of variability in nicotine delivery across devices and users (Farsalinos et al., 2014; Bullen et al., 2010) , evidence suggests that some electronic cigarette products may deliver as much nicotine as conventional cigarettes (Ramoa et al., 2016; Wagener et al., 2016) . Because lung development in utero and in childhood contributes to lifelong trajectories of lung function, the effects of prenatal exposure to nicotine could have negative effects on respiratory health in middle-aged and older adults, including increased risk of asthma and chronic obstructive pulmonary disease (COPD) (Lange et al., 2015; Martinez, 2009; Stern et al., 2007) . In addition, human and animal studies of prenatal tobacco and nicotine effects on cardiorespiratory function provide strong evidence that fetal nicotine exposure compromises the fetal and neonatal response to hypoxic stress, which could contribute to the pathophysiology underlying SIDS.
The integration of human and animal studies of behavioral and cognitive outcomes associated with nicotine exposure is complex, but also demonstrates areas of close alignment. Maternal cigarette smoking in humans and nicotine exposure in animals have been consistently associated with auditory processing deficits, which could affect language development and speech comprehension. Rigorous studies of prenatal tobacco exposure in humans using innovative approaches to address potential confounding from genetic and environmental factors have found associations with externalizing behavioral outcomes in offspring. Furthermore, animal studies of gestational nicotine exposure provide support for the underlying biological mechanisms that could explain deficits observed in humans, notably nicotine's actions on nAChRs. nAChRs play unique roles in development, and exposure to nicotine, even at very low levels, disrupts those developmental processes.
Human and animal studies of adolescent exposure to cigarette smoking and nicotine also have areas of convergence. It is well established from human and animal research that adolescents are highly vulnerable to addiction to nicotine (U.S. Department of Health and Human Services, 2012) . More recent animal studies demonstrate a "priming" effect of nicotine that increases vulnerability to addiction to other drugs. Studies of human adolescent smokers also find deficits in working memory, attention, and auditory processing, and adolescent nicotine exposure in rodents is associated with deficits in learning and in attention, as well as in increased impulsivity and anxiety. Prospective studies of child and adolescent drug exposure, such as the recently launched Adolescent Brain Cognitive Development Study (National Institutes of Health, 2016), could yield additional data from subjects exposed to non-combustible tobacco products, such as smokeless tobacco and electronic cigarettes, helping to quantify the effects of nicotine exposure on cognitive, behavioral, and mental health outcomes. Finally, nicotine withdrawal in adolescent tobacco users can cause impairments in cognition and has adverse effects on mood and attention (Jacobsen et al., 2005; Jacobsen et al., 2007c; Fried et al., 2006) .
The evidence presented in this review has often been overlooked in discussions about the relative harms and risks of electronic cigarettes, perhaps in part because of the paucity of studies of isolated nicotine exposure in humans. Randomized trials of nicotine exposure in humans that could determine effects of nicotine on development are unethical, so researchers rely on observational studies of human smokers. Human smokers, however, are exposed not only to nicotine, but to hundreds of other toxic components generated by combustion, such as carbon monoxide, acetaldehyde, and polycyclic aromatic hydrocarbons. In addition, there are numerous methodological challenges inherent in studies of smokers, including residual confounding from socioeconomic, environmental, genetic and other factors. Although considerable progress has been made in overcoming these limitations, controlled animal experiments remain a critically important supplement to human studies in establishing the consequences of nicotine exposure. In fact, rodent models historically have served as the "gold standard" for evaluating developmental neurotoxicants (Slotkin, 2004; Claudio et al., 2000) , and regulatory decisions on product safety are routinely made using animal data. Of particular relevance to nicotine is the example of chlorpyrifos, an acetylcholinesterase inhibitor and widely-used organophosphate insecticide that leads to inappropriate overstimulation of cholinergic receptors similar to that caused by nicotine (Slotkin, 1999) . 1 Despite the strength of data in support of adverse effects of nicotine exposure during pregnancy and adolescence, important research gaps remain that, if addressed, could better characterize these effects. An improved understanding of how the timing of nicotine exposure during pregnancy affects fetal development could lead to more effective strategies to limit nicotine's effects, such as intensified efforts to promote cessation by a specific gestational age or prior to conception. Research could also expand our understanding of the relative contributions of nicotine and products of combustion to effects on brain development and cognitive outcomes in adolescence. Indeed, several recent studies indicate that other tobacco smoke components amplify the adverse effects of nicotine, and that even the low levels of nicotine exposure associated with secondhand smoke are injurious to fetal brain development and cognitive function (Slotkin et al., 2015; Slotkin et al., 2014; Hall et al., 2016) .
Recently, important steps were taken that will help protect vulnerable populations from exposure to nicotine. The Child Nicotine Poisoning Prevention Act, which requires child-resistant containers for liquid nicotine e-cigarette cartridges, was signed into law in February 2016 (Child Nicotine Poisoning Prevention Act, 2016). In May 2016, the U.S. Food and Drug Administration finalized a rule extending its authority to all tobacco products, including electronic cigarettes. Federal law will require health warnings on electronic cigarette packages and advertisements that read "WARNING: This product contains nicotine. Nicotine is an addictive chemical.The law prohibits the sale of electronic cigarettes to individuals under the age of 18 years, the sale of electronic cigarettes in vending machines, and the distribution of free samples (Food and Drug Administration and HHS, 2016) . In the future, additional potentially effective strategies could include strong prohibitions on electronic cigarette marketing to reduce youth uptake, health warnings specific to pregnant women and adolescents, and protection from exposure to secondhand electronic cigarette aerosol. Measures could also include consideration of the impact of pricing on youth initiation and use; product addiction potential and youth appeal, including youth-oriented flavorings; accessibility of products through placement in retail venues; and social networking potential. In addition, policies related to the age of legal sale of electronic cigarettes and other nicotine-containing products could benefit if informed by our knowledge of the developmental stages during which humans are most vulnerable to the adverse effects of nicotine. Because the brain does not reach full maturity until the mid-20s (Giedd, 2004) , restricting sales of electronic cigarettes and all tobacco products to individuals aged at least 21 years and older could have positive health benefits for adolescents and young adults. Finally, it is important for clinicians to deliver a clear message that nicotine adversely affects health by providing unequivocal advice to pregnant women and adolescents to avoid the use of all tobacco products, as well as exposure to both secondhand smoke and secondhand aerosol. If these measures are accompanied by intensification of established comprehensive tobacco control programs as recommended by CDC (Centers for Disease Control and Prevention, 2014), they would be expected to have an even greater impact.
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